Cargando…

‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports

BACKGROUND: NPS belonging to the benzodiazepine (BZD) class, e.g., ‘legal/designer BZDs’/‘research chemicals’, have recently emerged in the drug (mainly online/virtual) market. OBJECTIVE: While certain NPS belonging to the BZD class possess pharmacological profiles similar to controlled pharmaceutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orsolini, Laura, Corkery, John M., Chiappini, Stefania, Guirguis, Amira, Vento, Alessandro, De Berardis, Domenico, Papanti, Duccio, Schifano, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569319/ https://www.ncbi.nlm.nih.gov/pubmed/31933443 http://dx.doi.org/10.2174/1570159X18666200110121333

Ejemplares similares

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
por: Orsolini, Laura, et al.
Publicado: (2018)

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review
por: Orsolini, Laura, et al.
Publicado: (2017)

The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity
por: Catalani, Valeria, et al.
Publicado: (2021)

The Psychonauts’ World of Cognitive Enhancers
por: Napoletano, Flavia, et al.
Publicado: (2020)

Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?
por: Orsolini, Laura, et al.
Publicado: (2017)

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective
por: Orsolini, Laura, et al.
Publicado: (2019)

Novel Opioids: Systematic Web Crawling Within the e-Psychonauts’ Scenario
por: Arillotta, Davide, et al.
Publicado: (2020)

The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic  Cannabinoids’ Information Available Online
por: Zangani, Caroline, et al.
Publicado: (2020)

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
por: Orsolini, Laura, et al.
Publicado: (2019)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
por: Schifano, Fabrizio, et al.
Publicado: (2018)

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems
por: Schifano, Fabrizio, et al.
Publicado: (2019)

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Schifano, Fabrizio, et al.
Publicado: (2019)

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
por: Chiappini, Stefania, et al.
Publicado: (2020)

Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports
por: Chiappini, Stefania, et al.
Publicado: (2021)

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
por: Chiappini, Stefania, et al.
Publicado: (2023)

COVID-19: The Hidden Impact on Mental Health and Drug Addiction
por: Chiappini, Stefania, et al.
Publicado: (2020)

Alprazolam-related deaths in Scotland, 2004–2020
por: Corkery, John Martin, et al.
Publicado: (2022)

New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
por: Chiappini, Stefania, et al.
Publicado: (2021)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
por: Chiappini, Stefania, et al.
Publicado: (2022)

‘Z-trip’? A Comprehensive Overview and a Case-series of Zolpidem Misuse
por: Orsolini, Laura, et al.
Publicado: (2021)

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
por: Catalani, Valeria, et al.
Publicado: (2021)

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)
por: Chiappini, Stefania, et al.
Publicado: (2022)

The Benzydamine Experience: A Systematic Review of Benzydamine Abuse
por: Stefania, Chiappini, et al.
Publicado: (2021)

COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
por: Arillotta, Davide, et al.
Publicado: (2021)

Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants
por: Schifano, Fabrizio, et al.
Publicado: (2021)

Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population
por: Chiappini, Stefania, et al.
Publicado: (2023)

Exploring e-psychonauts perspectives towards cocaine effects and toxicity
por: Assi, Sulaf, et al.
Publicado: (2022)

Misuse of Anticholinergic Medications: A Systematic Review
por: Chiappini, Stefania, et al.
Publicado: (2022)

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach
por: Arillotta, Davide, et al.
Publicado: (2023)

Piloting the UK’s First Home-Office-Licensed Pharmacist-Led Drug Checking Service at a Community Substance Misuse Service
por: Guirguis, Amira, et al.
Publicado: (2020)

Is There a Potential of Misuse for Venlafaxine and Bupropion?
por: Schifano, Fabrizio, et al.
Publicado: (2018)

Pregabalin: A range of misuse‐related unanswered questions
por: Schifano, Fabrizio, et al.
Publicado: (2019)

Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports
por: Schifano, Fabrizio, et al.
Publicado: (2018)

What about “Pharming”? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs
por: Chiappini, Stefania, et al.
Publicado: (2020)

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues
por: Chiappini, Stefania, et al.
Publicado: (2023)

Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK
por: Gittins, Rosalind, et al.
Publicado: (2018)

What About Drug Checking? Systematic Review and Netnographic  Analysis of Social Media
por: Guirguis, Amira, et al.
Publicado: (2020)

The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
por: Sharif, Safia, et al.
Publicado: (2021)

Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances
por: Ramos, Camille, et al.
Publicado: (2020)

Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?
por: Coppola, Maurizio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v381iirat0db60b1rd6do25jp6